MCID: PRT017
MIFTS: 20

Peritoneal Serous Papillary Adenocarcinoma

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Peritoneal Serous Papillary Adenocarcinoma

MalaCards integrated aliases for Peritoneal Serous Papillary Adenocarcinoma:

Name: Peritoneal Serous Papillary Adenocarcinoma 12 15
Primary Serous Papillary Carcinoma of Peritoneum 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6228
NCIt 50 C7695
SNOMED-CT 67 15674004
UMLS 70 C1368918

Summaries for Peritoneal Serous Papillary Adenocarcinoma

MalaCards based summary : Peritoneal Serous Papillary Adenocarcinoma, also known as primary serous papillary carcinoma of peritoneum, is related to primary peritoneal serous/papillary carcinoma and papillary adenocarcinoma. An important gene associated with Peritoneal Serous Papillary Adenocarcinoma is PIP (Prolactin Induced Protein). The drugs Doxorubicin and Atrasentan have been mentioned in the context of this disorder. Affiliated tissues include breast, and related phenotypes are Increased viability and cardiovascular system

Related Diseases for Peritoneal Serous Papillary Adenocarcinoma

Graphical network of the top 20 diseases related to Peritoneal Serous Papillary Adenocarcinoma:



Diseases related to Peritoneal Serous Papillary Adenocarcinoma

Symptoms & Phenotypes for Peritoneal Serous Papillary Adenocarcinoma

GenomeRNAi Phenotypes related to Peritoneal Serous Papillary Adenocarcinoma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased viability GR00386-A-1 8.32 WT1

MGI Mouse Phenotypes related to Peritoneal Serous Papillary Adenocarcinoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.46 CLDN4 PIP PTGER4 WT1
2 cellular MP:0005384 9.26 CLDN4 PIP PTGER4 WT1
3 hematopoietic system MP:0005397 8.92 CLDN4 PIP PTGER4 WT1

Drugs & Therapeutics for Peritoneal Serous Papillary Adenocarcinoma

Drugs for Peritoneal Serous Papillary Adenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
2
Atrasentan Investigational Phase 2 173937-91-2, 195733-43-8 159594
3 Antibiotics, Antitubercular Phase 2
4
Liposomal doxorubicin Phase 2 31703
5 taxane Phase 2
6 Endothelin Receptor Antagonists Phase 2
7 Anti-Bacterial Agents Phase 2
8 Endothelin A Receptor Antagonists Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Phase II Study of Atrasentan (ABT-627) Plus DOXIL in Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Serous Papillary Adenocarcinoma Following Platinum + Taxane Therapy Terminated NCT00653328 Phase 2 atrasentan hydrochloride;doxil

Search NIH Clinical Center for Peritoneal Serous Papillary Adenocarcinoma

Genetic Tests for Peritoneal Serous Papillary Adenocarcinoma

Anatomical Context for Peritoneal Serous Papillary Adenocarcinoma

MalaCards organs/tissues related to Peritoneal Serous Papillary Adenocarcinoma:

40
Breast

Publications for Peritoneal Serous Papillary Adenocarcinoma

Articles related to Peritoneal Serous Papillary Adenocarcinoma:

# Title Authors PMID Year
1
[A case of peritoneal serous papillary carcinoma]. 61
21829076 2011
2
[A case of peritoneal serous papillary adenocarcinoma]. 61
19295280 2009
3
Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis? 61
18339419 2008
4
Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. 61
17609977 2007
5
Peritoneal serous papillary adenocarcinoma: report of four cases. 61
16258208 2005
6
Repetitive phosphorus-32 peritoneal instillations in a patient with malignant ascites. 61
12819405 2003
7
Two cases of peritoneal serous papillary adenocarcinoma. 61
1721482 1991

Variations for Peritoneal Serous Papillary Adenocarcinoma

Expression for Peritoneal Serous Papillary Adenocarcinoma

Search GEO for disease gene expression data for Peritoneal Serous Papillary Adenocarcinoma.

Pathways for Peritoneal Serous Papillary Adenocarcinoma

GO Terms for Peritoneal Serous Papillary Adenocarcinoma

Sources for Peritoneal Serous Papillary Adenocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....